| 2011 |
Sec16B localizes to ER exit sites (transitional ER) and acts as a scaffold for COPII coat assembly, defining ER exit sites in mammalian cells. Unlike Sec16A, overexpressed Sec16B targets to the entire ER membrane rather than remaining cytosolic. |
Overexpression, immunofluorescence localization, RNAi knockdown |
Scientific reports |
Medium |
22355596
|
| 2011 |
Sec16B, but not Sec16A, is required for ER-to-peroxisome transport of peroxisomal membrane biogenesis factors Pex16 and Pex3 in mammalian cells. Knockdown of Sec16B by RNAi altered peroxisome morphology and inhibited Pex16 transport from the ER to peroxisomes; these phenotypes were rescued by RNAi-resistant Sec16B. |
RNAi knockdown, overexpression, rescue experiment, immunofluorescence, Western blot |
Proceedings of the National Academy of Sciences of the United States of America |
High |
21768384
|
| 2011 |
The C-terminal region of Sec16B, which is not conserved in Sec16A, is required for its role in transporting peroxisomal biogenesis factors from the ER to peroxisomes, and this function occurs at ER areas other than canonical ER exit sites. |
Domain deletion analysis, overexpression, localization studies |
Cellular logistics |
Medium |
22279616
|
| 2023 |
Intestinal SEC16B is required for dietary lipid absorption and chylomicron secretion in mice. Intestinal-specific knockout of Sec16b impaired ApoB lipidation and chylomicron secretion, resulting in reduced postprandial serum triglyceride output and protection from high-fat diet-induced obesity, particularly in female mice. |
Intestinal knockout mouse model, acute oil challenge, fasting/refeeding assays, biochemical and imaging analyses |
Molecular metabolism |
High |
36796587
|
| 2023 |
A homozygous missense mutation in SEC16B causes accumulation of type I procollagen in the ER and a general ER trafficking defect, leading to ER stress, enhanced autophagosome formation, and increased apoptosis in patient fibroblasts. Transfection of wild-type SEC16B into patient cells rescued collagen trafficking. The defect was due to reduced SEC16B expression rather than altered protein function. |
Patient fibroblast analysis, wild-type SEC16B rescue transfection, ER stress assays, autophagosome imaging |
EMBO molecular medicine |
Medium |
36916446
|
| 2020 |
Sec16B is an ER stress-inducible gene regulated via a functional unfolded protein response element (UPRE) in its promoter that responds to ER stress inducers and spliced XBP1 (sXBP1) overexpression. A unique ATF4-responsive sequence within the first intron also regulates Sec16B transcription. |
Microarray analysis, luciferase reporter assay, ER stress induction (thapsigargin, brefeldin A), sXBP1 overexpression |
Molecular and cellular biochemistry |
Medium |
32815086
|
| 2025 |
SEC16B deficiency in mice impairs glucose homeostasis by reducing glucose-stimulated insulin secretion in pancreatic beta cells, through downregulation of cholinergic signaling and compromised intracellular Ca2+ influx. This function is conserved, as dSec16 knockdown in Drosophila also triggers glucose intolerance. |
Sec16b knockout mouse model, Drosophila RNAi knockdown, glucose and insulin tolerance tests, immunostaining, glucose-stimulated insulin secretion assays, RNA-seq of pancreatic islets |
Diabetologia |
High |
40705078
|
| 2026 |
Hepatic SEC16B promotes VLDL secretion and lipid droplet (LD) expansion to maintain lipid homeostasis. SEC16B partially localizes at ER-LD contact sites and facilitates targeting of ER proteins to LDs. Hepatic Sec16b deficiency decreases serum lipid levels by impairing VLDL secretion through mechanisms at least partially independent of MTP-mediated ApoB lipidation and COPII-mediated trafficking. Suppression of Sec16b reduces atherosclerotic lesion size in Ldlr null mice. |
Hepatic knockout mouse model, VLDL secretion assays, lipid droplet imaging, ER-LD contact site localization, atherosclerosis model (Ldlr null mice) |
The Journal of clinical investigation |
High |
42030462
|
| 2026 |
SEC16B is a tissue-selective modulator of the COPII machinery critical for efficient secretion of APOB-containing lipoproteins in the liver. SEC16B acts as a molecular brake to fine-tune COPII condensation for lipoprotein export. Hepatic deletion of SEC16B in mice markedly reduces circulating APOB, triglycerides and cholesterol, and confers protection against atherosclerosis and cardiac dysfunction. SEC16B expression is regulated in an HNF4A-dependent manner. |
Hepatic knockout mouse model, integrative bioinformatics, AI-driven structural prediction, UK Biobank data mining, atherosclerosis model |
The EMBO journal |
High |
42032080
|
| 2009 |
RGPR-p117 (SEC16B) was identified as a transcription factor that binds the TTGGC(N)6CC nuclear factor I consensus motif in the regucalcin gene promoter region, using a yeast one-hybrid system. It translocates from cytoplasm to nucleus via protein kinase C signaling following hormonal stimulation, and phosphorylated RGPR-p117 enhances regucalcin mRNA expression. |
Yeast one-hybrid system, immunocytochemistry, Western blot, PKC signaling inhibitor experiments |
Molecular and cellular biochemistry |
Medium |
19214710
|
| 2006 |
RGPR-p117 (SEC16B) overexpression enhances regucalcin gene promoter activity in NRK52E cells via the TTGGC motif at the -523/-435 region. This enhancing effect requires phosphorylation/dephosphorylation events mediated by multiple kinases including PKC, PI3K, and tyrosine kinases. |
Luciferase reporter assay with wild-type and deletion constructs, kinase/phosphatase inhibitor treatment, stable transfection |
Journal of cellular biochemistry |
Medium |
16676356
|
| 2005 |
RGPR-p117 (SEC16B) localizes to both cytoplasm and nucleus in NRK52E kidney cells, and its nuclear localization is accompanied by stimulation of regucalcin mRNA expression upon overexpression. |
Immunocytochemistry, Western blot fractionation, stable transfection |
International journal of molecular medicine |
Low |
16211248
|
| 2022 |
RGPR-p117 (SEC16B) overexpression in NRK-52E cells suppresses cell proliferation by decreasing levels of Ras, PI3K, Akt, MAPK, and mTOR while increasing p53, Rb, p21, and regucalcin. RGPR-p117 overexpression also blocks proliferation stimulated by calcium entry agonist (Bay K 8644) and PKC activator (PMA), and increases nuclear translocation of RGPR-p117. |
Stable overexpression, colony formation assay, Western blot for signaling components, nuclear translocation assay |
Life sciences |
Low |
35853523
|